Research
Molecular
Newer classes of antihyperglycemic agents have beneficial effects on several cardiovascular risk factors.
Healthcare providers should consider prescribing newer antihyperglycemic agents for their cardiovascular benefits.
StrongSupportsmedium confidence
Newer classes of antihyperglycemic agents have been associated with beneficial effects on several CV risk factors.
Why this rating
The claim is based on multiple studies evaluating these newer agents.
Source
A Multifactorial Approach to Reduce Cardiovascular Disease in Type 2 Diabetes Mellitus: Now More Than Ever
Jan Basile · Hospital Practice · 2016
reviewCited 1×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →